Related Experiment Video
Updated: Dec 25, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
All About the Core: A Therapeutic Strategy to Prevent Protein Accumulation with Proteasome Core Particle Stimulators
Rachel A Coleman1, Darci J Trader1
1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 West Stadium Avenue, West Lafayette, Indiana 47907, United States.
Abstract:
The proteasome is an essential enzyme complex in cells whose main responsibility is to degrade proteins. Proteins can be degraded through either a ubiquitin-dependent or -independent mechanism by the proteasome. A variety of small molecules have been discovered that can increase the rate of protein degradation through either mechanism. However, stimulation of the ubiquitin-independent system is likely to be the most therapeutically impactful for protein-accumulation diseases. Preliminary evidence has demonstrated efficacy of this approach for reducing proteins associated with disease. To advance the field forward, validation of this mechanism in a disease model as well as more detailed studies on how much stimulation is required to achieve a therapeutic effect must be performed.
Insights
The proteasome degrades proteins via ubiquitin-dependent or -independent pathways. Stimulating the ubiquitin-independent system offers therapeutic potential for protein-accumulation diseases.
Area of Science:
- Cellular Biology
- Biochemistry
- Enzymology
Background:
- The proteasome is a critical cellular complex responsible for protein degradation.
- Protein degradation occurs through ubiquitin-dependent and ubiquitin-independent mechanisms.
- Small molecules can modulate proteasome activity, influencing protein degradation rates.
Discussion:
- Stimulation of the ubiquitin-independent proteasome pathway holds significant therapeutic promise for protein-accumulation diseases.
- Preliminary studies suggest this approach can effectively reduce disease-associated proteins.
- Further research is needed to validate this mechanism in disease models.
Key Insights:
- Targeting the ubiquitin-independent proteasome pathway is a promising therapeutic strategy.
- Small molecules offer a means to modulate proteasome function.
- Efficacy in disease models requires further investigation.
Outlook:
- Validation of proteasome stimulation in disease models is crucial.
- Determining optimal stimulation levels for therapeutic effect is necessary.
- This research paves the way for novel treatments for protein-accumulation disorders.
More Related Videos
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
11:57Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
Published on: April 21, 2016
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
The Proteasome Structure
The proteasome is an...
Drugs that Stabilize Microtubules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...